Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Andrew Nelson

Orthopaedic Surgery Galena, KS Medical Doctor

NPI 1861810541 CMS profile 1313788

444 Four States Dr Ste 1, Galena, KS 66739

Open in the dashboard

General payments

$12,463

124 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Andrew Nelson of Galena, KS is reported in the CMS Open Payments database as having received $12,463 across 124 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,107 36
2024 General $4,231 35
2023 General $861 9
2022 General $439 6
2021 General $355 5
2020 General $1,977 16
2019 General $1,494 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Nelson
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Andrew Nelson were reported at $3,107. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Andrew Nelson Orthopaedic Surgery median Middle half National median
2019 $1,494 $644 $140–$2,844 $163
2020 $1,977 $312 $75–$1,860 $114
2021 $355 $520 $117–$2,495 $132
2022 $439 $598 $128–$2,731 $149
2023 $861 $461 $128–$2,264 $160
2024 $4,231 $497 $134–$2,475 $164
2025 $3,107 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $7,605 79 payments
  2. Zimmer Biomet Holdings, Inc. $1,852 18 payments
  3. Maxx Orthopedics, Inc. $1,763 7 payments
  4. Medical Device Business Services, Inc. $345 3 payments
  5. Davol Inc. $182 3 payments
  6. Becton, Dickinson and Company $155 1 payment
  7. Titan Surgical Group, LLC $127 2 payments
  8. Medtronic USA, Inc. $94 1 payment
  9. DePuy Synthes Sales Inc. $91 1 payment
  10. Heron Therapeutics, Inc. $80 1 payment
  11. Other $168 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,336 114 payments
  2. Travel and Lodging $1,781 7 payments
  3. Education $345 3 payments
Products named General payments · program years 2019–2025
  1. MAKO Knees, Hips $4,773 49 payments
  2. MAKO Knees, Hips $1,659 18 payments
  3. G7 $1,109 7 payments
  4. TRITANIUM Hips $564 5 payments
  5. INSIGNIA $508 5 payments
  6. RESTORATION $497 3 payments
  7. TRIDENT $454 2 payments
  8. ACCOLADE $454 2 payments
  9. TRITANIUM Hips $454 2 payments
  10. GAMMA $442 4 payments
  11. Other $2,899 40 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

612

Median for Orthopedic Surgery: 203

Drug cost

$5,268

Median for Orthopedic Surgery: $1,433

Branded share of claims

4.1%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 42 $2,610
Gabapentin Generic 118 $654
Doxycycline Hyclate Generic 38 $627
Oxycodone Hcl Generic 96 $612
Meloxicam Generic 190 $400
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 25 $224
Amoxicillin Generic 71 $60
Clindamycin Hcl Generic 13 $40
Tramadol Hcl Generic 19 $40

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$198,719

Of which drugs: $9,075

Medicare patients

505

Average age 73

Services billed

2,681

327 women, 178 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 30%
Diabetes 29%
Depression 27%
Chronic kidney disease 25%
Heart failure 20%
Atrial fibrillation 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 143 627 $2,977

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

124 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record